News

Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 26, J.P.
Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Zacks Investment Research on MSN2d
Johnson & Johnson (JNJ) Could Be a Great Choice
Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.Johnson & Johnson in ...
Johnson & Johnson faces legal pressures from talc lawsuits, likely to create persisting growth and valuation headwinds. Read ...
According to Johnson & Johnson’s 2023 Health for Humanity Report, the company sought to have 50% of its management positions held by women and 6.8% of management slots held by Black and African ...
A federal court denied Johnson & Johnson's motion to implement a 340B drug rebate model, siding with HHS and hospitals who ...
Tylenol wasn’t just a top seller for Johnson & Johnson; it was the company’s most important and iconic product. “Sales in 1982 were expected to approach $500 million and account for nearly ...
Nurix Therapeutics is subleasing 159,959 square feet of former Johnson & Johnson office space at 1600 Sierra Point Parkway in ...
Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, discusses the importance of ...